SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-028654
Filing Date
2021-05-24
Accepted
2021-05-24 11:20:16
Documents
45
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_biomxinc.htm 10-Q 468607
2 CERTIFICATION f10q0321ex31-1_biomxinc.htm EX-31.1 7918
3 CERTIFICATION f10q0321ex31-2_biomxinc.htm EX-31.2 8639
4 CERTIFICATION f10q0321ex32_biomxinc.htm EX-32 8491
  Complete submission text file 0001213900-21-028654.txt   2682937

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE phge-20210331.xml EX-101.INS 502802
6 XBRL SCHEMA FILE phge-20210331.xsd EX-101.SCH 33773
7 XBRL CALCULATION FILE phge-20210331_cal.xml EX-101.CAL 23111
8 XBRL DEFINITION FILE phge-20210331_def.xml EX-101.DEF 133201
9 XBRL LABEL FILE phge-20210331_lab.xml EX-101.LAB 268003
10 XBRL PRESENTATION FILE phge-20210331_pre.xml EX-101.PRE 139794
Mailing Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38762 | Film No.: 21952082
SIC: 2836 Biological Products, (No Diagnostic Substances)